July 17th 2024
A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
New study shows that vitamin K2 as MK-7 may have neuroprotective qualities
May 17th 2024Researchers examined the effects of MK-7 and menaquinone-4 (MK-4) on neuroblastoma cells to understand how different forms of vitamin K2 impact the expression of genes involved in neurodegeneration and neuroinflammation.
Kyowa Hakko to showcase new functional beverage featuring its Cognizin Citicoline at Expo West 2024
February 21st 2024Kyowa Hakko has announced that Karma Water has a new product featuring its Cognizin Citicoline ingredient to promote energy and enhance focus. The company will be providing samples at Expo West 2024.
OSHU to investigate effects of Gotu kola extract in subjects with Alzheimer’s Disease
January 8th 2024OSHU explains that the pilot study will not test memory directly, but rather use blood samples and brain scans to find biomarkers and other signs that indicate the extract’s ability to aid memory.